Salud

Starting a more gradual dosing schedule for Eli Lilly’s Alzheimer’s disease drug Kisunla reduces the percentage of patients suffering from potentially serious brain swelling, according

GSK on Wednesday said sales of its vaccines would fall this year after weaker-than-expected sales results for respiratory syncytial virus (RSV) and shingles vaccines in

Tuberculosis has replaced COVID-19 to become the leading cause of death from infectious diseases in 2023, according to a World Health Organisation report released Tuesday

Pfizer reported higher-than-expected profits due to strong sales of COVID treatment Paxlovid, a major victory for chief executive Albert Bourla as he takes on activist

Swiss dental implant maker Straumann on Tuesday reported double-digit percentage growth in organic revenue for the third quarter as more people seek dental services globally,

Swiss drugmaker Novartis on Tuesday raised its 2024 profit forecast for the third time amid greater use of its prescription drugs such as psoriasis and

Sun Pharmaceuticals, India’s largest drugmaker by revenue, reported second-quarter profit above analysts’ estimates, helped by higher demand for its speciality drugs used to treat rare

French drugmaker Sanofi posted stronger third-quarter profit growth than analysts expected, helped by an earlier-than-expected start to the vaccination season. The company’s quarterly operating income,

Pfizer’s quarterly financial report released on Tuesday coincided with a critical moment for the US drugmaker and its CEO, as activist hedge fund Starboard Value

French drugmaker Sanofi on Friday posted stronger third-quarter profit growth than analysts expected, helped by an earlier-than-expected start to the vaccination season.